Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,481 total articles
NewtekOne, Inc., a financial holding company offering a range of business and financial solutions, announced participation and presentations at three investor conferences in May 2026. The company will engage with investors through presentations and one-on-one meetings to highlight its diverse services including banking, lending, electronic payment …
Fate Therapeutics reported Q1 2026 financial results and business updates, highlighting the planned initiation of the Phase 2 RECLAIM-LN trial of FT819 in lupus nephritis patients in H2 2026. The FDA selected FT819 into the CDRP program to accelerate development, and the company presented positive clinical and preclinical data for FT819 and FT839 a…
NEXGEL, Inc. announced the appointment of Dave Hazard as Vice President of Sales for its newly formed BIONX Surgical division. The move supports the commercialization efforts following a transformative acquisition aimed at significantly scaling revenue. Hazard brings extensive experience in orthopedics, spine, and biologics sales leadership, positi…
SRx Health Solutions has invested more than 10% of its investable capital in Astro Investment XVII, an affiliate of Astro Capital that holds investments in SpaceX and other AI and space-related companies. This move aligns the company with high-growth technology sectors and follows its merger agreement with EMJ Crypto Technologies, aiming to leverag…
Intelligent Bio Solutions Inc. announced a significant 46% year-over-year revenue increase to $1.06 million for fiscal third quarter 2026, driven by a 59% rise in cartridge sales which now constitute 66% of quarterly revenue. The company also reported improved gross profit margins exceeding 50%, enhanced operational efficiencies through new manufac…
Vor Bio reported financial results for Q1 2026 with $491.5 million in cash to fund operations into early 2029, ongoing global Phase 3 trials for telitacicept in generalized myasthenia gravis and primary Sjögren's disease, and anticipates topline data in H1 2027. The company highlights the potential of telitacicept to become a foundational therapy i…
Lite Strategy, Inc. reported its fiscal 2026 third quarter results, highlighting successful execution of its covered call option program that generated $0.7 million in net proceeds and deployment of these proceeds plus Litecoin tokens to repurchase over 1.6 million shares. The company emphasized the recent SEC guidance classifying Litecoin (LTC) as…
Bicara Therapeutics granted inducement stock options to newly appointed Chief Commercial Officer, Christopher Sarchi, under its 2026 Inducement Plan to encourage his employment. The options comprise 282,240 shares at the closing Nasdaq price on May 8, 2026, and vest over four years. Bicara focuses on developing bifunctional therapies targeting soli…
Aware, Inc. announced that its Intelligent Liveness biometric solution underwent an independent evaluation by BixeLab, aligned with the CEN/TS 18099 technical specification. The system faced 900 test scenarios including 600 injection attack attempts and 300 bona fide transactions, with zero successful bypasses and zero errors, demonstrating strong …
Brunswick Corporation published its 2025 Sustainability Report, showcasing substantial progress in environmental initiatives, product development, and employee safety. The company exceeded its renewable electricity goals, significantly reduced greenhouse gas emissions, introduced over 100 new products, and maintained favorable employee safety metri…
Bath & Body Works, Inc. is set to release its Q1 2026 financial results on May 27, 2026, before market open. The company will hold a conference call with its CEO and CFO to discuss the results and provide a business update. Supplemental materials and webcast will be available through the company's investor relations website.
SS Innovations International, Inc. reported a significant increase in Q1 2026 revenue to $11.1 million, up 116.8% from Q1 2025, driven by strong growth in installations and surgeries of its SSi Mantra surgical robotic system. Gross margin expanded substantially to 48%, and net loss narrowed compared to the prior year period. Key achievements includ…
EpicQuest Education Group International Limited, trading as EEIQ on Nasdaq, highlights milestones including the first year of profitability at Davis University, significant growth in international student enrollment, and strategic collaborations expanding their global higher education footprint. The company focuses on innovative international progr…
Astrotech Corporation reported its third-quarter fiscal year 2026 financial results with declining R&D expenses as it moves from development to commercialization. The company deployed its TRACER 1000 system across multiple countries and maintains a healthy sales pipeline amid disciplined cost control and strategic investments. Revenue declined comp…
Candel Therapeutics, a clinical-stage biopharmaceutical company developing multimodal immunotherapies for cancer, announced that its CEO, Paul Peter Tak, will present at the Stifel 2026 Virtual Targeted Oncology Forum and the 2026 Jefferies Global Healthcare Conference. The company highlighted progress in its lead product candidates, including agla…
Quantum Cyber N.V. has entered into an exclusive IP License Agreement with BP United Inc., securing innovative autonomous drone technology to advance its Quantum-ready defense platform. This move aligns with the Trump administration's significant $55 billion budget request for drone and autonomous warfare programs, marking a historic increase and s…
Allegro MicroSystems, a leader in power and sensing semiconductor solutions, announced its participation in TD Cowen's 54th Annual Technology, Media & Telecom Conference on May 27, 2026. The company's EVP and CFO, Derek D'Antilio, will deliver a fireside chat, further communicating Allegro's advancements and positioning in electrification, automati…
Sionna Therapeutics announced that its management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference to discuss its development of novel medicines targeting cystic fibrosis. The company focuses on stabilizing the CFTR protein's NBD1 domain to improve treatment outcomes for CF patients, leveraging a pipe…
Century Therapeutics reported Q1 2026 financial results and updates on its induced pluripotent stem cell (iPSC)-derived therapies. The company remains on track to submit an IND for CNTY-813, a type 1 diabetes islet therapy, by Q4 2026 with initial clinical data expected in the second half of 2027. Additionally, Century plans to initiate clinical tr…
Silexion Therapeutics announced the commencement of GMP clinical batch manufacturing for SIL204, their next-generation siRNA therapy targeting mutated KRAS in locally advanced pancreatic cancer. The company also received ethics committee approval from Tel Aviv Sourasky Medical Center to conduct a Phase 2/3 clinical trial of SIL204, marking critical…
Foremost Clean Energy Ltd. announced successful completion of its 2026 drilling program at the Hatchet Lake South Uranium Project in northern Saskatchewan, expanding the Tuning Fork Uranium Zone with multiple significant uranium mineralization intercepts. The program included 19 diamond drill holes with high-grade results supporting continued explo…
One Stop Systems, Inc. (Nasdaq: OSS), a US-based leader in rugged high performance AI and machine learning compute solutions for edge applications, announced its participation in Special Operations Forces Week from May 19 to 21, 2026. The company will demonstrate its rugged AI compute products designed for defense applications, collaborating with i…
Verrica Pharmaceuticals announced that its CEO will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference held at NASDAQ, highlighting its dermatological therapeutics pipeline including FDA-approved YCANTH® for molluscum contagiosum and development programs for common warts and non-melanoma skin cancers.
Cerence Inc., a leader in conversational AI-powered automotive experiences, announced its participation in the TD Cowen 54th Annual Technology, Media & Telecom Conference. Its CEO and CFO will engage in a fireside chat and one-on-one investor meetings, highlighting company strategies and innovations in AI and automotive technology.
TTEC Digital has entered a strategic collaboration agreement with Amazon Web Services to enhance adoption of Amazon Connect by integrating AI-powered customer experience solutions, simplifying contact center modernization. This partnership aims to deliver intelligent self-service, agent assistance, and real-time data capabilities to organizations, …
